# Temozolomide in Aggressive Pituitary Neuroendocrine Tumors: A Latin American Multicenter Retrospective Cohort (TMZ-LATAM)

> **NCT07695844** · — · NOT_YET_RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Pituitary Neoplasms

## Interventions

- **DRUG:** temozolamide
- **DRUG:** Temozolamide

## Key facts

- **NCT ID:** NCT07695844
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2028-12-10
- **Final completion:** 2028-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695844, "Temozolomide in Aggressive Pituitary Neuroendocrine Tumors: A Latin American Multicenter Retrospective Cohort (TMZ-LATAM)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07695844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*